share_log

贵州三力(603439.SH):子公司拟与关联人共同增资成都维度时代

Guizhou Sanli Pharmaceutical Co.,Ltd. (603439.SH): Subsidiary plans to increase capital with related parties in Chengdu Dimension Era.

Gelonghui Finance ·  Sep 20 07:10

On September 20, Guizhou Sanli Pharmaceutical Co., Ltd. (603439.SH) announced that in order to promote the company's business development, its wholly-owned subsidiary Sanli Health plans to jointly increase capital with Chuangyong, Yao Zunbao, and Cheng'an technology to Chengdu Dimensional Era, with a total capital increase of 70 million yuan. This transaction is based on the registered capital valuation. After the completion of this transaction, the registered capital of Chengdu Dimensional Era will increase from 10 million yuan to 80 million yuan. Sanli Health, the company's wholly-owned subsidiary, will subscribe for 20 million yuan, holding a 25.00% stake; Chuangyong will subscribe for 34.8 million yuan, holding a 43.50% stake; Yao Zunbao will subscribe for 14 million yuan, holding a 17.50% stake; the original shareholder Chengdu Xinlan Internet Information Consulting Partnership (limited partnership) will subscribe for 4.8 million yuan, holding a 6.00% stake; Cheng'an Technology will subscribe for 6.4 million yuan, holding an 8.00% stake. The parties involved have signed the "Investment Agreement of Chengdu Dimensional Era Technology Co., Ltd.", and the final capital increase result will be subject to the approval of the Industry and Commerce Department.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment